{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:01:06Z","timestamp":1790380866061,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cmi.2026.09.024","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:18:11Z","timestamp":1790378291000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recommendations for beta-lactam antibiotic dose individualisation in acutely ill patients"],"prefix":"10.1016","author":[{"given":"Rekha PAI","family":"MANGALORE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"HUTTNER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit C.P.","family":"KOCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"ROBERTS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.09.024_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13054-023-04527-1","article-title":"International survey of antibiotic dosing and monitoring in adult intensive care units","volume":"27","author":"Williams","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2026.09.024_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s13054-020-03272-z","article-title":"Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)","volume":"24","author":"Abdulla","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2026.09.024_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2334-12-152","article-title":"DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic","volume":"12","author":"Roberts","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2026.09.024_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","article-title":"Therapeutic drug monitoring of \u03b2-lactams in critically ill patients: proof of concept","volume":"36","author":"Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2026.09.024_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2026.107883","article-title":"Prospective evaluation of therapeutic target attainment with a beta-lactam dosing nomogram in critically ill adult patients","volume":"67","author":"Williams","year":"2026","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2026.09.024_bib6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/jac\/dkad223","article-title":"The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting","volume":"78","author":"Pai Mangalore","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.09.024_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115421","article-title":"Model-informed precision dosing: State of the art and future perspectives","volume":"215","author":"Minichmayr","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cmi.2026.09.024_bib8","volume":"46","author":"Barreto","year":"2026","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2026.09.024_bib9","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.cmi.2026.09.024_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40265-018-0880-z","article-title":"Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?","volume":"78","author":"Muller","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2026.09.024_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101681","article-title":"Unraveling the impact of therapeutic drug monitoring via machine learning for patients with sepsis","volume":"5","author":"Ates","year":"2024","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.cmi.2026.09.024_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000001505","article-title":"Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015\u20132024)","author":"Morales Junior","year":"2026","journal-title":"Ther Drug Monit"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26005409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26005409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:18:12Z","timestamp":1790378292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26005409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":12,"alternative-id":["S1198743X26005409"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.09.024","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for beta-lactam antibiotic dose individualisation in acutely ill patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}